酪氨酸激酶抑制剂相关治疗药物监测的研究进展(7)
[21] REDDICK SJ，CAMPAGNE O，HUANG J，et al. Pharmacokinetics and safety of erlotinib and its metabolite OSI- 420 in infants and children with primary brain tumors[J]. Cancer Chemother Pharmacol，2019，84(4)：829-838.[22] GAO B，YEAP S，CLEMENTS A，et al. Evidence for the- rapeutic drug monitoring of targeted anticancer therapies[J]. J Clin Oncol ......
您现在查看是摘要页，全文长 2680 字符。